Impartner Showcases Ecosystem Momentum at the 2025 EMEA Partner Experience Summit
30.6.2025 10:30:00 CEST | Business Wire | Press Release
Impartner, the leader in partner relationship management (PRM), hosted partnership and channel leaders at its EMEA Partner Experience Summit in London. Part of the Multiply ImpartnerCon World Tour, the event focused on the future of ecosystem-led growth, from AI-powered strategy to automated engagement and scalable partner programmes.
The summit provided a strategic forum for organisations evolving their approach to partner-led revenue growth. Sessions focused on operational excellence, ecosystem orchestration, and modernising channel strategy.
Featured Speakers and Sessions
- Building a Winning Partner Program with efficy - Jasper Lounio, Global Head of Channel at efficy, used the analogy of a relay race to illustrate successful partnerships rely on shared effort, where no single team can succeed alone. He stressed the need for clean handovers, cross-functional ownership and AI-fueled collaboration to deliver a seamless, trusted partner experience.
- Boosting Engagement: Mambu's Journey to Impartner PX - Anthony Nonnis, Global Head of Partnerships, and Selin Bas, Partner Operations Specialist at Mambu, shared how they use Impartner PX™ to unify operations, centralise data and deepen partner loyalty, helping partners move faster and make more strategic decisions.
- Ecosystem Compass: Signals Redefining Partner Strategy - Teddy Ludmer, Senior Alliance Manager at Tipalti, and Eleanor Thompson, Founder of Branchworks, and chapter leads with Partnership Leaders, presented findings from the Partnership Leaders’ 2025 Ecosystem Compass Report. Their insights explored the decentralisation of partner influence, the rise of orchestration tools, and the shift toward value-based partnerships.
- News on Demand: Driving Engagement Through Automation - Attendees received a first-hand look at the latest innovations in News on Demand, Impartner’s powerful solution for scalable, automated partner communications led by Impartner’s Iolo Dafydd and Mike Cotton. A follow-on panel with Monica Gavrila, Global Digital Marketing Automation Senior Manager at Vertiv, and Nils Henrik Haga, Partner Enablement Manager at boost.ai shared how they leverage the solution to streamline partner communications. They explained how News on Demand helps optimize campaign setup, improves targeting precision, and enhances visibility across partner journeys.
Attendees joined insightful roundtable discussions to exchange ideas on topics including AI and the future of partner programmes, operationalising high-return MDF strategies and boosting partner engagement and loyalty. The day concluded with networking, sponsored by INFUSE, allowing attendees to continue building connections and exchange insights.
“There’s no denying it; partnerships are evolving fast. What we saw in London was a community of ecosystem leaders not only embracing change, but leading it,” said Impartner’s VP of Marketing, Trevor Burnett. “From AI-powered orchestration to new communication tactics, this summit was about turning ideas into action. We’re proud of the momentum we’re building together.”
The EMEA Partner Experience Summit underscored the strong momentum in the region, reflecting rising demand for data-driven solutions that scale indirect revenue and strengthen partner relationships. Impartner remains committed to sustaining this momentum and will continue to host events across the region, including sponsoring Partnership Leaders’ Catalyst Europe event on October 23, 2025, in London.
About Impartner
Impartner is the fastest-growing, most awarded provider of channel management technologies, including its flagship Partner Relationship Management (PRM) and Partner Marketing Automation solutions. These tools empower organizations worldwide to effectively manage partner relationships, drive demand through partners, and accelerate revenue via indirect sales channels. For more information, visit www.impartner.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250630536811/en/
Contacts
For media inquiries, please contact:
Lola Phonpadith
Lola.phonpadith@impartner.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom